• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Prognostic significance and therapeutic implications of Caveolin-1 in gastrointestinal tract malignancies

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Kamposioras, Konstantinos
    Vassilakopoulou, M.
    Anthoney, A.
    Bariuoso, Jorge
    Mauri, D.
    Mansoor, Was
    Papadopoulos, V.
    Dimas, K.
    Affiliation
    Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Caveolin-1 (CAV1) is expressed in several solid tumors both in cancerous cells as well as in tumor stroma and is reported to be related to cancer progression, metastasis, therapy resistance and clinical outcomes. Many studies report contrasting functions of this protein depending on the tumor cell model, the tumor type, or the stage of cancer studied. This protein is reported to function both as tumor suppressor and as tumor promoter. In this review, we aim to summarize translational and clinical studies that provide evidence of the role of CAV1 in tumor progression and survival outcome focusing on tumors of the gastrointestinal (GI) tract. Towards this aim, a detailed search has been performed for studies on the expression and the role of CAV1 in oesophageal, gastric, colorectal, pancreatic cancer and cholangiocarcinoma prognosis. We also review and discuss the implication of CAV1 in the outcome of pharmacological interventions. We conclude that CAV1 has the potential to become an important prognostic, and possibly predictive, biomarker in GI malignancies. It may also become a novel target towards the development of improved cancer therapies. However, it is obvious that there remains a lack of consensus on important issues such as the methodologies and cut-off levels in caveolin assessment. This ultimately result in many studies being contradictory not only in terms of the role of CAV1 as a tumor-promoting or suppressing gene but also in terms of the tumor compartment in which the levels of this protein may be of clinical significance. Addressing these important technical issues, in conjunction with a further elucidation of the role of CAV1 in tumor formation and progression, will delineate the importance of CAV1 in prognostic and therapeutic perspectives.
    Citation
    Kamposioras K, Vassilakopoulou M, Anthoney A, Bariuoso J, Mauri D, Mansoor W, et al. Prognostic significance and therapeutic implications of Caveolin-1 in gastrointestinal tract malignancies [Internet]. Pharmacology & Therapeutics. Elsevier BV; 2021. p. 108028.
    Journal
    Pharmacology and Therapeutics
    URI
    http://hdl.handle.net/10541/624784
    DOI
    10.1016/j.pharmthera.2021.108028
    PubMed ID
    34755606
    Additional Links
    https://dx.doi.org/10.1016/j.pharmthera.2021.108028
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.pharmthera.2021.108028
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Caveolin-1 protein expression as a prognostic biomarker of gastrointestinal tumours: A systematic review and meta-analysis.
    • Authors: Kamposioras K, Dinas PC, Barriuoso J, Trachana V, Dimas K
    • Issue date: 2023 Dec
    • Caveolin-1, cancer and therapy resistance.
    • Authors: Ketteler J, Klein D
    • Issue date: 2018 Nov 1
    • Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer.
    • Authors: Nam KH, Lee BL, Park JH, Kim J, Han N, Lee HE, Kim MA, Lee HS, Kim WH
    • Issue date: 2013
    • Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer.
    • Authors: Godina C, Belting M, Vallon-Christersson J, Isaksson K, Bosch A, Jernström H
    • Issue date: 2024 Mar 20
    • Caveolin-1, breast cancer and ionizing radiation.
    • Authors: Pucci M, Bravatà V, Forte GI, Cammarata FP, Messa C, Gilardi MC, Minafra L
    • Issue date: 2015 May-Jun
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.